NEFROLOGIA
Scope & Guideline
Fostering dialogue for a healthier tomorrow in nephrology.
Introduction
Aims and Scopes
- Chronic Kidney Disease (CKD) Management:
The journal emphasizes research on the prevention, diagnosis, and management of chronic kidney disease. This includes studies on risk factors, progression, and treatment strategies, particularly involving lifestyle interventions and pharmacological therapies. - Dialysis and Transplantation:
Research related to dialysis modalities (hemodialysis and peritoneal dialysis) and kidney transplantation is a core focus. This includes studies on outcomes, complications, and innovations in dialysis techniques, as well as the management of transplant recipients. - Cardiorenal Interactions:
The intersection of cardiovascular health and kidney disease is increasingly highlighted. The journal publishes research exploring the shared risk factors, pathophysiological mechanisms, and treatment implications of cardiorenal syndromes. - Nephrology Innovations and Technology:
There is a consistent focus on innovative approaches in nephrology, including the use of technology for remote monitoring, telemedicine, and novel therapies such as SGLT2 inhibitors and other emerging pharmacological agents. - Patient-Centered Care and Quality of Life:
Research that addresses the psychosocial aspects of kidney disease, including quality of life, patient education, and the impact of chronic kidney disease on daily living, is a prominent theme. - Epidemiology and Public Health:
The journal often features epidemiological studies that assess the prevalence and impact of kidney diseases in various populations, aiming to inform public health strategies and policies.
Trending and Emerging
- Impact of COVID-19 on Kidney Health:
Recent publications increasingly address the implications of COVID-19 on kidney disease, including acute kidney injury in COVID-19 patients and the long-term effects on renal health. This theme is crucial given the pandemic's profound impact on nephrology. - Telemedicine and Remote Monitoring:
The rise of telemedicine and remote patient monitoring has become a significant focus, especially in the context of ongoing health challenges. Studies evaluating the efficacy and patient outcomes of these technologies are gaining traction. - Diabetic Kidney Disease and Metabolic Disorders:
Emerging research emphasizes the interplay between diabetes and kidney disease, particularly how metabolic disorders influence renal health. This includes studies on SGLT2 inhibitors and their role in managing diabetic kidney disease. - Personalized Medicine Approaches:
There is a growing interest in personalized medicine within nephrology, with research exploring genetic factors and individualized treatment plans for kidney disease, reflecting a broader trend in healthcare towards tailored therapies. - Social Determinants of Health:
Research addressing social determinants of health, including socioeconomic factors influencing kidney disease management and outcomes, is becoming more prevalent, highlighting the need for interdisciplinary approaches to patient care.
Declining or Waning
- Traditional Biomarkers in Nephrology:
There is a noticeable decline in studies focusing solely on traditional biomarkers for kidney disease, such as serum creatinine, as the field moves towards more comprehensive assessments that include novel biomarkers and advanced imaging techniques. - Basic Science Research:
While fundamental research is still relevant, there seems to be a waning focus on purely basic science studies without direct clinical implications. The journal increasingly prioritizes translational research that bridges laboratory findings with clinical applications. - Invasive Diagnostic Procedures:
Research centered on invasive procedures, such as kidney biopsies, has decreased as non-invasive diagnostic methods and imaging technologies gain traction. There is a growing preference for studies that highlight minimally invasive approaches.
Similar Journals
SEMINARS IN DIALYSIS
Pioneering research and insights in kidney health.SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.
Kidney Medicine
Transforming the landscape of kidney medicine.Kidney Medicine is a pioneering Open Access journal dedicated to advancing the field of nephrology and internal medicine, published by Elsevier. Since its inception in 2019, it has rapidly established itself as a vital resource, currently ranked in the Q2 category for Internal Medicine and Q1 for Nephrology by 2023, reflecting its influence and critical contributions to both disciplines. With an impressive Scopus ranking, positioning it at #24 out of 81 in Nephrology, the journal serves as an essential platform for researchers, clinicians, and students eager to disseminate and access high-quality research. By providing open access to a diverse array of articles, Kidney Medicine ensures that vital research reaches a wide audience, thereby facilitating knowledge exchange and innovation within the community. Its ongoing commitment to excellence and relevance makes it a key player in shaping the future of kidney health worldwide.
PEDIATRIC NEPHROLOGY
Empowering clinicians with cutting-edge nephrology insights.Pediatric Nephrology, published by Springer, is a leading international journal dedicated to advancing the field of pediatric nephrology and enhancing the health of children with renal disorders. With its ISSN 0931-041X and E-ISSN 1432-198X, this esteemed journal has been in circulation since 1987 and has established itself as a vital resource for researchers and clinicians alike. Featuring a robust impact factor and categorized in Q1 for Pediatrics, Perinatology and Child Health, and Q2 for Nephrology, Pediatric Nephrology stands at the forefront of medical literature, reflecting its commitment to disseminating high-quality research. The journal is particularly noted for its comprehensive scope, encompassing clinical studies, innovative treatments, and cutting-edge research findings that shape pediatric kidney care. Located in Germany and reaching a global audience, this journal not only supports the academic community but also plays a crucial role in improving health outcomes for children worldwide. Access to its valuable content is essential for any practitioner or researcher invested in the evolving landscape of pediatric medicine.
NEPHROLOGY DIALYSIS TRANSPLANTATION
Illuminating the path of kidney health through rigorous scholarship.NEPHROLOGY DIALYSIS TRANSPLANTATION is a premier academic journal published by Oxford University Press that plays a vital role in disseminating cutting-edge research within the fields of nephrology and transplantation. With an impressive impact factor and recognition as Q1 in both these categories for 2023, the journal ranks among the top publications in medicine, enhancing its visibility among a global audience of researchers, healthcare professionals, and students. Established in 1986, the journal has maintained a commitment to publishing high-quality, peer-reviewed articles that contribute to the advancement of knowledge and practice in renal medicine. Although this journal does not offer open access options, it remains a highly regarded resource due to its rigorous selection process and influential contributions to the field. Scholars are encouraged to explore the journal’s extensive archive, spanning from 1986 to 2024, for invaluable insights and developments in nephrology and transplantation.
KIDNEY & BLOOD PRESSURE RESEARCH
Elevating the Standards of Nephrology and Cardiology Research.Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.
THERAPEUTIC APHERESIS AND DIALYSIS
Enhancing therapeutic approaches for improved health solutions.THERAPEUTIC APHERESIS AND DIALYSIS is an esteemed journal published by Wiley, focusing on the fields of hematology and nephrology. Since its inception in 2003, the journal has provided a dedicated platform for research and advancements in therapeutic apheresis and dialysis methodologies, offering valuable insights for clinicians and researchers alike. With an ISSN of 1744-9979 and an E-ISSN of 1744-9987, the journal has established itself within Q3 in both the hematology and nephrology categories. Its Scopus rankings place it at #44 in nephrology and #79 in hematology, indicating its growing influence in these critical areas of medical research. Although it does not currently offer open access, THERAPEUTIC APHERESIS AND DIALYSIS remains a vital resource for professionals aiming to stay at the forefront of innovations and practices through 2024 and beyond. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and discussions presented within its pages, solidifying its role in enhancing patient care and therapeutic strategies.
AMERICAN JOURNAL OF KIDNEY DISEASES
Pioneering Discoveries: Your Gateway to Kidney Health ExcellenceThe American Journal of Kidney Diseases, published by W B Saunders Co-Elsevier Inc, stands as a premier academic resource in the field of nephrology, with an impressive impact factor that highlights its significance in advancing kidney health research. Since its inception in 1981, this journal has consistently provided a platform for innovative studies and critical reviews that shape clinical practices and policies in kidney disease management, achieving a prestigious Q1 ranking within the nephrology category as of 2023. With an H-index reflective of its research dynamism and influence, the journal has become an essential read for professionals, researchers, and students keen on the latest scientific advancements. While the journal does not offer Open Access, it continues to maintain high standards for the quality and relevance of its published content, making it indispensable for those dedicated to understanding and combating kidney diseases. Its address is located in Philadelphia, PA, further solidifying its commitment to fostering knowledge in the United States and beyond.
Turkish Journal of Nephrology
Connecting researchers to enhance kidney healthcare strategies.Turkish Journal of Nephrology, published by AVES, serves as a pivotal platform for disseminating significant research in the domains of nephrology, transplantation, and surgery. Since its establishment as an Open Access journal in 2019, it has gained traction for delivering high-quality, peer-reviewed articles that reflect the latest advancements and practices in these critical medical fields. Based in Turkey, this journal has rapidly become an important resource, particularly for researchers and healthcare professionals striving to enhance kidney healthcare strategies. Despite being categorized in the fourth quartile across its main categories for 2023 and having modest rankings within Scopus, its commitment to openness and accessibility fosters a collaborative academic environment that promotes knowledge sharing. We encourage scholars, practitioners, and students to engage with the journal's content to further drive innovation and improve patient outcomes in nephrology and associated disciplines.
Clinical and Experimental Nephrology
Elevating nephrology: where research meets practice.Clinical and Experimental Nephrology, published by SPRINGER, serves as a crucial platform for researchers and practitioners in the field of nephrology. With its roots dating back to 1999, the journal has made significant strides in exploring various dimensions of kidney health, thereby enriching our understanding of nephrological diseases. Aimed at fostering interdisciplinary dialogue, it covers a broad spectrum of topics from clinical practices to experimental research, evidenced by its ranked quartiles of Q2 in Nephrology and Q3 in both Physiology and Medical Physiology within its latest evaluation. Although not open access, the journal's rigorous peer-review process ensures the publication of high-quality research, making it a valuable resource for professionals, academic institutions, and students. The journal is located in Japan, with its editorial office situated at One New York Plaza, Suite 4600, New York, NY 10004, United States, reflecting its global influence and intent to disseminate critical findings in nephrology and beyond.
Nephrologie & Therapeutique
Uniting research and practice in kidney disease management.Nephrologie & Therapeutique is a distinguished peer-reviewed journal published by JOHN LIBBEY EUROTEXT LTD, dedicated to the field of nephrology. Since its inception in 2005, this journal has been pivotal in disseminating high-quality research in the areas of kidney disease, renal therapies, and nephrological advancements, and it continues to serve as an essential resource for professionals, researchers, and students alike. With an ISSN of 1769-7255 and an E-ISSN of 1872-9177, the journal is indexed in Scopus and is currently ranked in the third quartile (Q3) within the nephrology category, showing significant contributions to the discipline, despite its current ranking of 64 out of 81. Although Nephrologie & Therapeutique does not operate under an open access model, it nevertheless provides valuable insights and updates on the latest findings and practices in nephrology, making it an important platform for academic discourse in this field. The journal's commitment to advancing knowledge and fostering interdisciplinary dialogue underscores its role as a key player in shaping future research and clinical practices in nephrology.